abstract |
Crystalline forms of (S) - 2 -amino- 3 - (4 - (2 -amino- 6 - ( (R) - 1 - (4 - chloro- 2 - (3 -methyl - lH-pyrazol - 1 -yl) phenyl) - 2, 2, 2 - trifluoroethoxy) pyrimidin - 4 -yl) phenyl) propanoic acid and salts thereof are disclosed. Pharmaceutical dosage forms and methods of their use are also disclosed. |